Scholars Central

Editorial Board Member

Xu Han

Chief Technology Officer, University of Miami, USA

About

As published by the journal they serve.

Xu Han is a cofounder and Chief Technology Officer at MD3 LLC, which is a mobile diagnosis detection device company, and C-Dots LLC which mainly focus on drug discovery. He obtained PhD degree from the University of Miami, FL, US. From 2008 to 2012, he achieved Bachelor of Science in chemistry from Nankai University, China, and Bachelor of Engineering from Nankai University and Tianjin University in chemical engineering from Tianjin University, China. He serves as the reviewer at Bioconjugate Chemistry, Journal of Colloid and Interface Science, Microchimica Acta, Colloids and Surfaces B: Biointerfaces, Future Science OA, BAOJ Chemistry, Recent Patents on Material Science, Journal of Parkinson’s Disease andAlzheimer's Disease, International Journal of Analytical Chemistry and other peer review journals. His research mainly focuses on Drug Delivery System, Biosensing Nanotechnology, Protein or Peptide Fibrillation, and Nanolithography.

Research interests

  • His research mainly focuses on Drug Delivery System
  • Biosensing Nanotechnology
  • Protein or Peptide Fibrillation
  • and Nanolithography. Certificate

Journals they serve

The seats these journals name them in.

Articles we hold

Articles in the journals they serve whose byline carries this name.

No article in our collection carries this name on its byline. Not every article names its authors in a way that can be matched, so this is not a list of everything they have written.

This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.